Abstract |
Male breast cancer (MBC) is a rare hormone-driven disease often associated with obesity. HMG-CoAR is the central enzyme of the mevalonate pathway, a molecular route deputed to produce cholesterol and steroid-based hormones. HMG-CoAR regulates the oncogenic Hippo transducers TAZ/YAP whose expression was previously associated with shorter survival in MBC. 225 MBC samples were immunostained for HMG-CoAR and 124 were considered eligible for exploring its relationship with hormone receptors (ER, PgR, AR), Hippo transducers and survival outcomes. HMG-CoAR was positively associated with the expression of hormone receptors (ER, PgR, AR) and Hippo transducers. Overall survival was longer in patients with HMG-CoAR-positive tumors compared with their negative counterparts (p = 0.031). Five- and 10-year survival outcomes were better in patients whose tumors expressed HMG-CoAR (p = 0.044 and p = 0.043). Uni- and multivariate analyses for 10-year survival suggested that HMG-CoAR expression is a protective factor (HR 0.50, 95% CI: 0.25-0.99, p = 0.048 and HR 0.53, 95% CI: 0.26-1.07, p = 0.078). Results were confirmed in a sensitivity analysis by excluding uncommon histotypes (multivariate Cox: HR 0.45, 95% CI: 0.21-0.97, p = 0.043). A positive relationship emerged between HMG-CoAR, hormone receptors and TAZ/YAP, suggesting a connection between the mevalonate pathway, the hormonal milieu and Hippo in MBC. Moreover, HMG-CoAR expression may be a favorable prognostic indicator.
|
Authors | Anna Di Benedetto, Marcella Mottolese, Francesca Sperati, Cristiana Ercolani, Luigi Di Lauro, Laura Pizzuti, Patrizia Vici, Irene Terrenato, Abeer M Shaaban, Sreekumar Sundara-Rajan, Matthew P Humphries, Maddalena Barba, Valerie Speirs, Ruggero De Maria, Marcello Maugeri-Saccà |
Journal | Scientific reports
(Sci Rep)
Vol. 6
Pg. 35121
(10 07 2016)
ISSN: 2045-2322 [Electronic] England |
PMID | 27713571
(Publication Type: Journal Article)
|
Chemical References |
- Adaptor Proteins, Signal Transducing
- Intracellular Signaling Peptides and Proteins
- Phosphoproteins
- Receptors, Androgen
- Receptors, Estrogen
- Receptors, Progesterone
- Trans-Activators
- Transcription Factors
- Transcriptional Coactivator with PDZ-Binding Motif Proteins
- WWTR1 protein, human
- YAP-Signaling Proteins
- YAP1 protein, human
- Cholesterol
- Hydroxymethylglutaryl CoA Reductases
- Protein Serine-Threonine Kinases
|
Topics |
- Adaptor Proteins, Signal Transducing
(biosynthesis)
- Adult
- Aged
- Aged, 80 and over
- Breast Neoplasms, Male
(mortality, pathology)
- Cholesterol
(biosynthesis)
- Gene Expression Regulation, Neoplastic
- Hippo Signaling Pathway
- Humans
- Hydroxymethylglutaryl CoA Reductases
(metabolism)
- Intracellular Signaling Peptides and Proteins
(biosynthesis)
- Male
- Middle Aged
- Phosphoproteins
(biosynthesis)
- Protein Serine-Threonine Kinases
(biosynthesis)
- Receptors, Androgen
(metabolism)
- Receptors, Estrogen
(metabolism)
- Receptors, Progesterone
(metabolism)
- Retrospective Studies
- Trans-Activators
- Transcription Factors
- Transcriptional Coactivator with PDZ-Binding Motif Proteins
- Treatment Outcome
- YAP-Signaling Proteins
|